Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
1
Vi Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2019 Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Mammoth Biosciences201-500 employees • 1 role
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
CPTxVenture round $29M · 2 yr ago
About Us We build the medicines we wish existed CPTx is a genetic medicines company redefining how we treat disease using immune-silent…
Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…
Immitra BioVenture round $2.7M · 1 mo ago
Developing scalable in-vivo genomic medicine for blood disorders.
XyloCorVenture round $23M · 5 yr ago
Gene therapy for advanced coronary artery disease. XyloCor Therapeutics is focused on improving the lives of patients through our…

Overview

Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable, one-time treatments.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Zurich Switzerland
Regional office
50-200 est. staff
2 In der Breiti, Zürich, ZH, 8047, CH
company site